Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
WIKKON is a China-based medical device company focused on urology and shock wave therapy equipment. Founded in 1996 and headquartered in Shenzhen, the company develops and manufactures extracorporeal shock wave lithotripters for urinary stone treatment, extracorporeal shock wave therapy systems for erectile dysfunction and pain therapy, and urology imaging/treatment tables. WIKKON has described itself as a market leader in ESWL in China, with thousands of installed systems and distribution in more than 40 countries. In 2022, Advanced MedTech acquired a majority interest in the company to strengthen its urology platform and China manufacturing footprint. The business operates as a commercial-stage medtech manufacturer rather than a therapeutics developer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on WIKKON.